Status:
COMPLETED
Inflammatory Markers in Patients With Active Migraine Headaches
Lead Sponsor:
Westside Family Medical Center, P.C.
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Migraine
Eligibility:
All Genders
21-65 years
Brief Summary
The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, su...
Detailed Description
A random selection of patients both male and female from a primary care practice with a diagnosis of having migraine headaches will be enrolled. Thirty (30) patients will be recruited mainly from the ...
Eligibility Criteria
Inclusion
- Subjects must sign a written informed consent.
- Enrollment population would include males and females 21 years of age to 65 years of age.
- Non-migraine subjects will be allowed in the control group
- Have episodic migraine headaches
- Patients to satisfy the diagnosis of migraine headaches with aura, without aura or mixed.
- Must be able to differentiate migraine headaches from other headaches
Exclusion
- Any medical condition in the opinion of the investigator that would make the subject unsuitable for enrollment.
- Basilar or hemiplegic migraine headaches.
- Pregnant woman or a nursing mother
- History (within 1 year) or current evidence of drug or alcohol abuse.
- More than 15 migraine headaches per month
- Chronic daily headaches
- Chronic use of NSAIDs
- Current participation in a research study or within the last 30 days.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00471861
Start Date
May 1 2007
End Date
February 1 2009
Last Update
August 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westside Family Medical Center, P.C.
Kalamazoo, Michigan, United States, 49009